Drug class
Typhoid Vaccine
Typhoid vaccines comprise a class of immunobiological agents formulated to stimulate active immunity against enteric fever caused by the bacterium *Salmonella enterica* serovar Typhi. Read more about Typhoid Vaccine
5 drugs in this class 4 manufacturers
Drugs in Typhoid Vaccine
TYPHIM VI (typhoid vaccine VI capsular polysaccharide)
VIVOTIF (typhoid vacc,live,attenuated)
VIVOTIF (typhoid vacc,live,attenuated)
TYPHIM VI (typhoid vaccine VI capsular polysaccharide)
Typhoid vaccines comprise a class of immunobiological agents formulated to stimulate active immunity against enteric fever caused by the bacterium *Salmonella enterica* serovar Typhi.
Depending on the specific formulation—such as oral live-attenuated strains, parenteral capsular Vi polysaccharides, or protein-conjugated Vi polysaccharides—these vaccines function by inducing protective systemic humoral, mucosal, or T-cell–dependent immune responses against bacterial surface antigens.
Clinically, they are indicated for the prevention of typhoid fever in individuals traveling to endemic areas, household contacts of documented chronic carriers, and laboratory personnel routinely exposed to *S.
Typhi*, as well as for mass immunization programs in regions with significant disease burden.
-
drugs.com
Typhoid vaccines comprise a class of immunobiological agents formulated to stimulate active immunity against enteric fever caused by the bacterium *Salmonella enterica* serovar Typhi Depending on the specific formulation—such as oral live-attenuated strains, parenteral capsular Vi polysaccharides, or protein-conjugated Vi polysaccharides—these vaccines function by inducing protective systemic humoral, mucosal, or T-cell–dependent immune responses against bacterial surface antigens Clinically, th...
-
who.int
Typhoid vaccines comprise a class of immunobiological agents formulated to stimulate active immunity against enteric fever caused by the bacterium *Salmonella enterica* serovar Typhi Clinically, they are indicated for the prevention of typhoid fever in individuals traveling to endemic areas, household contacts of documented chronic carriers, and laboratory personnel routinely exposed to *S. Typhi*, as well as for mass immunization programs in regions with significant disease burden
-
coalitionagainsttyphoid.org
Depending on the specific formulation—such as oral live-attenuated strains, parenteral capsular Vi polysaccharides, or protein-conjugated Vi polysaccharides—these vaccines function by inducing protective systemic humoral, mucosal, or T-cell–dependent immune responses against bacterial surface antigens Clinically, they are indicated for the prevention of typhoid fever in individuals traveling to endemic areas, household contacts of documented chronic carriers, and laboratory personnel routinely e...
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.